United States · Bill · S
S. 417 (116th)
Changing the Culture of the FDA Act
Introduced
7 February 2019
Last action
7 February 2019 · Introduced
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
Sen. Manchin, Joe, III [I-WV]
Subjects
Healthcare
Source updated
21 April 2025
Summary
Changing the Culture of the FDA Act This bill requires the Food and Drug Administration to amend its mission statement to take responsibility for protecting the public health by considering the danger of addiction and overdose death when approving and regulating prescription opioid medications. (Opioid medications are drugs with effects similar to opium, such as certain pain medications.)
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
7 February 2019
Introduced
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Source: IntroReferral
7 February 2019
Introduced
Introduced in Senate
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in Senate · 7 February 2019 · Official file
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 7 February 2019
Introduced in Senate (PDF)
Introduced in Senate · EN · 7 February 2019
Introduced in Senate
summary · EN · 7 February 2019
Sponsors
- Sen. Manchin, Joe, III [I-WV] · D · Sponsor
- · sshr00 · Standing
Related records
- related to → Changing the Culture of the FDA Act
- related to ← Changing the Culture of the FDA Act
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/senate-bill/417
- Open data entity: https://api.congress.gov/v3/bill/116/s/417
- us · 116-s-417 · source updated 21 April 2025